Skip to main content

Table 3 Comparison of differential allelic expression between breast and blood (fresh and transformed)

From: Extent of differential allelic expression of candidate breast cancer genes is similar in blood and breast

Gene

SNP

Informative Heterozygotes

Wilcoxon rank sum test p- value

  

Blood

LCL

Breast

Blood vs LCL

Blood vs Breast

LCL vs Breast

BRCA1

rs799917

27

13

6

4.40E-06

0.011

0.016

BRCA2

rs144848

37

6

8

NA

0.744

NA

C1qA

rs172378

16

5

7

0.076

NA

NA

CCND3

rs1051130

17

12

7

0.207

0.266

0.090

EMSY

rs228611

37

7

13

2.26E-05

0.029

0.047

GPX1

rs1050450

14

4

12

NA

NA

NA

GPX4

rs713041

21

8

5

0.366

0.057

0.091

MLH3

rs175080

35

12

13

NA

NA

0.772

MTHFR

rs1801133

33

7

12

0.030

1.53E-04

0.703

NBS1

rs709816

21

9

13

0.003

0.001

0.947

TP53

rs1042522

16

8

16

0.192

1.34E-05

3.80E-04

TRXR2

rs1139793

29

9

14

0.069

0.826

0.007

  1. Wilcox rank sum tests were performed to compare deviations of differential allelic expression variance (only genes showing DAE were introduced in the analysis). Blood corresponds to fresh B cell samples and LCL to EBV transformed lymphoblastoid cell lines. DAE = differential allelic expression; LCL, EBV transformed lymphoblastoid cell lines.